MicroRNA let-7 and viral infections: focus on mechanisms of action

A Letafati, S Najafi, M Mottahedi, M Karimzadeh… - Cellular & Molecular …, 2022 - Springer
MicroRNAs (miRNAs) are fundamental post-transcriptional modulators of several critical
cellular processes, a number of which are involved in host defense mechanisms. In …

Immunopathology of RSV: an updated review

HC Bergeron, RA Tripp - Viruses, 2021 - mdpi.com
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …

[PDF][PDF] MicroRNAs in asthma and respiratory infections: identifying common pathways

S Taka, P Tzani-Tzanopoulou… - Allergy, asthma & …, 2019 - synapse.koreamed.org
MicroRNAs (miRs) are single-stranded RNAs of 18-25 nucleotides. These molecules
regulate gene expression at the post-transcriptional level; several of these are differentially …

Functional features of the respiratory syncytial virus G protein

LJ Anderson, SJ Jadhao, CR Paden, S Tong - Viruses, 2021 - mdpi.com
Respiratory syncytial virus (RSV) is a major cause of serious lower respiratory tract
infections in children< 5 years of age worldwide and repeated infections throughout life …

Micro-players of great significance—host microRNA signature in viral infections in humans and animals

E Ostrycharz, B Hukowska-Szematowicz - International Journal of …, 2022 - mdpi.com
Over time, more and more is becoming known about micro-players of great significance.
This is particularly the case for microRNAs (miRNAs; miR), which have been found to …

Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV)

HC Bergeron, RA Tripp - Expert Opinion on Investigational Drugs, 2022 - Taylor & Francis
Introduction Respiratory syncytial virus (RSV) is a leading cause of serious lower respiratory
tract infection (LRTI) in infants and young children. Palivizumab is an RSV-specific …

Non-coding RNAs and their role in respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) infections

W Wu, EJ Choi, I Lee, YS Lee, X Bao - Viruses, 2020 - mdpi.com
Recent high-throughput sequencing revealed that only 2% of the transcribed human
genome codes for proteins, while the majority of transcriptional products are non-coding …

PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-λ production

RB Werder, JP Lynch, JC Simpson, V Zhang… - Science translational …, 2018 - science.org
Prostaglandin D2 (PGD2) signals through PGD2 receptor 2 (DP2, also known as CRTH2) on
type 2 effector cells to promote asthma pathogenesis; however, little is known about its role …

Immunological goals for respiratory syncytial virus vaccine development

BS Graham - Current opinion in immunology, 2019 - Elsevier
Highlights•Immunological goals for vaccination depend on whether it is for primary induction
or boosting of pre-existing immunity.•Boosting neutralizing activity is the major goal for …

Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response

HC Bergeron, LM Kauvar… - Therapeutic Advances in …, 2023 - journals.sagepub.com
Background: Respiratory syncytial virus (RSV) is a poor inducer of antiviral interferon (IFN)
responses which result in incomplete immunity and RSV disease. Several RSV proteins …